AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 9215092
Drug: Valaciclovir 500
RxNorm normalized name: valacyclovir 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valaciclovir 500 mg twice daily
Trial: 19107321
Drug: Control foot
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control foot (no treatment)
Trial: 26539650
Drug: rosuvastatin 20
RxNorm normalized name: rosuvastatin 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rosuvastatin 20 mg
Trial: 26539650
Drug: atorvastatin 10
RxNorm normalized name: atorvastatin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: atorvastatin 10 mg
Trial: 23728830
Drug: atorvastatin 20
RxNorm normalized name: atorvastatin 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: atorvastatin 20 mg
Trial: 15356085
Drug: Flutamide (62.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flutamide (62.5 mg/d) plus metformin (850 mg/d) and ethinylestradiol-drospirenone (30 microg plus 3 mg, 21 d/month)
Trial: 15356085
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (metformin (850 mg/d) and ethinylestradiol-drospirenone (30 microg plus 3 mg, 21 d/month) without flutamide
Trial: 8162994
Drug: Prior inhalation
RxNorm normalized name: Priorix
DrugBank: Rubella virus vaccine (DB10317)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prior inhalation of a bronchodilator aerosol
Trial: 31889152
Drug: Standard anticoagulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard anticoagulation (enoxaparin and warfarin, n=35)
Trial: 23530484
Drug: Implantable cardioverter
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Implantable cardioverter defibrillator (ICD) therapy alone
Trial: 15630143
Drug: Sodium citrate
RxNorm normalized name: Sodium Citrate
DrugBank: Sodium nitrate (DB15952)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium citrate (0.5 g x kg(−1) body mass in 1.5 litres of solution)
Trial: 17292647
Drug: 60 mg
RxNorm normalized name: opium 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg codeine
Trial: 18053632
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg naltrexone
Trial: 9274760
Drug: Binocular visual
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Binocular visual direction with adjacent binocular objects; specific intervention details such as dosage and duration are not available.
Trial: 9274760
Drug: Monocular objects
RxNorm normalized name: Molecular AF
DrugBank: Tolnaftate (DB00525)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Monocular objects viewed in the presence of adjacent binocular objects; specific intervention details such as dosage and duration are not available.
Trial: 9274760
Drug: Nonius lines
RxNorm normalized name: Gallus gallus gizzard lining preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonius lines as indicators of eye position; specific intervention details such as dosage and duration are not available.
Trial: 1345049
Drug: Ketoprofen (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketoprofen (100 mg bid for 7 days)
Trial: 3739581
Drug: Supplementary dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supplementary dose of 20 ml mepivacaine 1% with adrenaline
Trial: 3739581
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no supplementary dose)
Trial: 25062713
Drug: Pitavastatin (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pitavastatin (2 mg/day)
Trial: 16464810
Drug: Intensive pharmaceutical
RxNorm normalized name: hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Intensive pharmaceutical care campaign targeting inappropriate use of triptans
Trial: 14725513
Drug: Esmolol (1mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esmolol (1mg x kg(‐1) bolus, followed by an infusion at 250 microg x kg(‐1)min(‐1))
Trial: 11328905
Drug: Dalteparin (initial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dalteparin (initial dose reduced to 50% if no clotting observed, approximately 5000 IU IV)
Trial: 30140582
Drug: Warfarin treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warfarin treatment
Trial: 10495794
Drug: Cyclosporine alone
RxNorm normalized name: Cyclosporine
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclosporine alone (monotherapy)
Trial: 10495794
Drug: Cyclosporine plus
RxNorm normalized name: Cyclosporine
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclosporine plus steroids (double therapy)
Trial: 10495794
Drug: Cyclosporine plus
RxNorm normalized name: Cyclosporine
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclosporine plus steroids plus azathioprine (triple therapy)
Trial: 8607489
Drug: Double therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Double therapy
Trial: 31841577
Drug: Intravenous acyclovir,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous acyclovir, 5 mg/kg, 3 times daily for 14 days
Trial: 25082852
Drug: No additional
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No additional preparation (Group 1)
Trial: 25082852
Drug: Commercial high-fat
RxNorm normalized name: Hard fat
DrugBank: Hard fat (DB11578)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Commercial high-fat solution containing 43.8 g of lipids (Group 2)
Trial: 25082852
Drug: 50 mL
RxNorm normalized name: TPN Bag 250 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mL of olive oil (Group 3)
Trial: 18480694
Drug: Mecamylamine hydrochloride
RxNorm normalized name: Mecamylamine Hydrochloride
DrugBank: Mecamylamine (DB00657)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mecamylamine hydrochloride (MEC) up to 10 mg/d; n = 11
Trial: 11210400
Drug: Oxybutynin XL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxybutynin XL 15 mg (fed treatment)
Trial: 29667290
Drug: Metformin 850
RxNorm normalized name: metFORMIN 850 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin 850 mg thrice daily for 52 months
Trial: 10150183
Drug: Trapidil (T)
RxNorm normalized name: trapidil
DrugBank: Trapidil (DB09283)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trapidil (T) 100 mg t.i.d.
Trial: 10150183
Drug: Aspirin (ASA)
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin (ASA) 100 mg t.i.d.
Trial: 27929203
Drug: Prasugrel (0.08
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prasugrel (0.08 mg/kg/day)
Trial: 7601080
Drug: 200mg oral
RxNorm normalized name: AVANAFIL 200MG ORAL TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200mg oral iodized oil
Trial: 7601080
Drug: 400mg oral
RxNorm normalized name: Mesna 400mg Oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400mg oral iodized oil
Trial: 28531241
Drug: Pravastatin sodium
RxNorm normalized name: Pravastatin Sodium
DrugBank: Pravastatin (DB00175)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pravastatin sodium (40 mg/d)
Trial: 23634822
Drug: Vaccine (CAF01-adjuvanted
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaccine (CAF01-adjuvanted HIV-1 peptides)
Trial: 17614012
Drug: Agonist and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Agonist and antagonist activity during MVC
Trial: 20191713
Drug: Experimental treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Experimental treatments
Trial: 9181163
Drug: Sequestration of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequestration of one unit of fresh autologous blood (5-8 ml/kg); Group I
Trial: 9181163
Drug: Sequestration of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequestration of two units of fresh autologous blood (12-15 ml/kg); Group II
Trial: 21619701
Drug: Growth hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone (GH) injections at a pharmacologic dose of 0.3 mg/kg/week
Trial: 19003734
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg vitamin C supplementation
Trial: 16816926
Drug: Ospemifene 90
RxNorm normalized name: Ospemifene
DrugBank: Ospemifene (DB04938)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Ospemifene 90 mg
Trial: 12443837
Drug: Ospemifene (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ospemifene (all doses)
Trial: 11740194
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment (PRO-PRE)
Trial: 9757959
Drug: Intramuscular methotrexate
RxNorm normalized name: Methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intramuscular methotrexate 50 mg/m2
Trial: 9757959
Drug: Intramuscular methotrexate
RxNorm normalized name: Methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intramuscular methotrexate 60 mg/m2
Trial: 9757959
Drug: Intramuscular methotrexate
RxNorm normalized name: Methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intramuscular methotrexate (both dosages)
Trial: 3145557
Drug: thrombolytic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: thrombolytic therapy (overall)
Trial: 28401417
Drug: Conventional oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional oral education (control group)
Trial: 1963015
Drug: Enoxaparin 40
RxNorm normalized name: ENOXAPARIN 40MG/0.4ML INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enoxaparin 40 mg/day
Trial: 19738135
Drug: Soluble intercellular
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soluble intercellular adhesion molecule-1
Trial: 16831981
Drug: Soluble interleukin-1
RxNorm normalized name: interleukin-1, beta
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soluble interleukin-1 receptor antagonist
Trial: 9590863
Drug: Diamox administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diamox administered preoperatively
Trial: 9590863
Drug: Mannitol or
RxNorm normalized name: mannitol Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mannitol or no drugs administered preoperatively
Trial: 7075651
Drug: Sotalol 320
RxNorm normalized name: sotalol 320 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sotalol 320 mg once daily
Trial: 6122937
Drug: Beta adrenoceptor
RxNorm normalized name: Beta Carotene
DrugBank: Beta carotene (DB06755)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta adrenoceptor blocking drugs
Trial: 30519893
Drug: Cefuroxime bolus-continuous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefuroxime bolus-continuous infusion targeting free serum cefuroxime concentrations of 64 mg/L
Trial: 28120603
Drug: High-dose nebulized
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose nebulized budesonide
Trial: 26591686
Drug: Yi Zhi
RxNorm normalized name: Zhi ma oil
DrugBank: Sesame oil (DB11172)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Yi Zhi Chan Tuina manipulation with 2 min treatment time
Trial: 20060945
Drug: IC41 vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IC41 vaccine
Trial: 16927534
Drug: Test formulation
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test formulation of lithium carbonate 300 mg
Trial: 12782436
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg morphine sulfate applied topically to the ulcer
Trial: 10947689
Drug: Intravenous epinephrine
RxNorm normalized name: Epinephrine
DrugBank: Epinephrine (DB00668)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous epinephrine (15 microg)
Trial: 6581064
Drug: Fenoterol powder
RxNorm normalized name: fenoterol
DrugBank: Fenoterol (DB01288)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenoterol powder (0.2 mg)
Trial: 6581064
Drug: Fenoterol aerosol
RxNorm normalized name: fenoterol
DrugBank: Fenoterol (DB01288)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenoterol aerosol (0.2 mg)
Trial: 26722003
Drug: Aspirin pretreatment
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin pretreatment
Trial: 22669347
Drug: IV morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV morphine 0.1 mg/kg with nasal and IM placebo
Trial: 22669347
Drug: IM morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IM morphine 0.1 mg/kg with nasal and IV placebo
Trial: 18201659
Drug: Subacromial injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subacromial injection of corticosteroids, local anesthetic, and contrast dye from anterolateral, lateral, or posterior locations
Trial: 18201659
Drug: Subacromial injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subacromial injection of corticosteroids, local anesthetic, and contrast dye
Trial: 16025045
Drug: Nasal steroid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nasal steroid use
Trial: 16234044
Drug: Nitazoxanide 500
RxNorm normalized name: nitazoxanide 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitazoxanide 500 mg (tablet) for patients aged 12 years or older, 200 mg (oral suspension) for patients aged 4-11 years, 100 mg (oral suspension) for patients aged 1-3 years, administered twice daily for 3 days.
Trial: 7954760
Drug: Combined oral
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined oral lysine acetylsalicylate and metoclopramide (LAS-MCP) 1620 mg lysine acetylsalicylate (equivalent to 900 mg aspirin) combined with 10 mg metoclopramide
Trial: 7954760
Drug: Combined oral
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined oral lysine acetylsalicylate and metoclopramide (LAS-MCP)
Trial: 3653766
Drug: Cisplatin (CDDP)
RxNorm normalized name: Cisplatin
DrugBank: Cisplatin (DB00515)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cisplatin (CDDP) 60 mg/m2 every 3 weeks
Trial: 3653766
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of cyclophosphamide, doxorubicin, and cisplatin (CAP)
Trial: 25885677
Drug: Oral prednisolone
RxNorm normalized name: prednisolone Oral Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral prednisolone (40 mg daily for 5 days)
Trial: 22845184
Drug: Written plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Written plus oral information before colonoscopy
Trial: 22845184
Drug: Oral information
RxNorm normalized name: Inflammation OTC Bruise
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral information before colonoscopy
Trial: 21266792
Drug: Medroxyprogesterone acetate
RxNorm normalized name: Medroxyprogesterone Acetate
DrugBank: Medroxyprogesterone acetate (DB00603)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Medroxyprogesterone acetate (MPA, 10 mg/day)
Trial: 21266792
Drug: Lynestrenol (LYN,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lynestrenol (LYN, 15 mg/day)
Trial: 21266792
Drug: Norethisterone (NET,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Norethisterone (NET, 15 mg/day)
Trial: 11777668
Drug: Buspirone and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buspirone and group therapy (12-week double-blind placebo-controlled trial)
Trial: 8424014
Drug: 1% lidocaine
RxNorm normalized name: Icy Hot Max 4%-1% Lidocaine Pain Relief Dry Topical Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1% lidocaine anesthesia (0.2 to 0.5 mL)
Trial: 26414973
Drug: 6 mg
RxNorm normalized name: boron 6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 mg melatonin before bedtime
Trial: 16828475
Drug: hCG injection
DrugBank: Chorionic Gonadotropin (Human) (DB09126)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: hCG injection 3-4 hours earlier (Group C)
Trial: 16828475
Drug: hCG injection
DrugBank: Chorionic Gonadotropin (Human) (DB09126)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: hCG injection at the same interval (Group B)
Trial: 16828475
Drug: hCG injection
DrugBank: Chorionic Gonadotropin (Human) (DB09126)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: hCG injection with >or=47% immature oocytes (Group A)
Trial: 8581442
Drug: Cold therapy
RxNorm normalized name: Deep Cold Therapy
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cold therapy (50 degrees F) for THA patients
Trial: 8581442
Drug: Cold therapy
RxNorm normalized name: Deep Cold Therapy
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cold therapy (not specified for TKA)
Trial: 8581442
Drug: Cold therapy
RxNorm normalized name: Deep Cold Therapy
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cold therapy and Control for both THA and TKA patients
Trial: 19346521
Drug: Candesartan-based therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Candesartan-based therapy
Trial: 19220756
Drug: R-137696 2
RxNorm normalized name: R
FDA approved: no
EMA approved: no
PMDA approved: no
Description: R-137696 2 mg t.i.d. for 4 weeks
Trial: 17224029
Drug: Fully rough
RxNorm normalized name: rough marshelder pollen extract
DrugBank: Iva annua pollen (DB10927)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fully rough implants (FR)
Trial: 15222523
Drug: 4 ml
RxNorm normalized name: ethanol 1.4 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 ml of 0.5% hyperbaric bupivacaine + 20 mg of fentanyl (Group F)
Trial: 15222523
Drug: 4 ml
RxNorm normalized name: ethanol 1.4 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 ml of 0.5% hyperbaric bupivacaine + 0.4 ml normal saline (Group S)
Trial: 12667371
Drug: Routine group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine group (dehydrant, antihypertensive agent, etc.)
Trial: 1958119
Drug: Linsidomine (0.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Linsidomine (0.8 mg)
Trial: 1958119
Drug: Nitroglycerin (0.15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitroglycerin (0.15 mg)
Trial: 19815152
Drug: Placebo at
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo at 1 hour before separator placement, 400 mg of ibuprofen at 3 hours and 7 hours after placement (Group B)
Trial: 11500337
Drug: Topical antimicrobial
RxNorm normalized name: GAUZE,ANTIMICROBIAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical antimicrobial prophylaxis (gentamicin/colistin/vancomycin 2% in Orabase, every 6 h)
Trial: 11500337
Drug: Topical antimicrobial
RxNorm normalized name: GAUZE,ANTIMICROBIAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical antimicrobial prophylaxis
Trial: 10204257
Drug: Rescue treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rescue treatment
Trial: 2660902
Drug: Intensive sequential
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive sequential chemotherapy
Trial: 23578031
Drug: Fluticasone furoate/vilanterol
RxNorm normalized name: fluticasone furoate/vilanterol 100/25 MCG/INHAL Dry Powder Inhaler, 30 Blisters
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluticasone furoate/vilanterol (FF/VI) 100/25 μg
Trial: 19692680
Drug: Gefitinib (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gefitinib (250 mg per day)
Trial: 24043283
Drug: Dexamethasone (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone (1 mg/kg, then 0.6 mg/kg for 4 more days)
Trial: 11092169
Drug: Adenosine, adenosine-receptor-agonists,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adenosine, adenosine-receptor-agonists, and dipyridamole prior to coronary angioplasty
Trial: 11092169
Drug: Glibenclamide (sulfonylurea
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glibenclamide (sulfonylurea drug therapy)
Trial: 9096687
Drug: Standard-dose mitoxantrone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-dose mitoxantrone (12 mg/m2 on days 1-3) with cytarabine (3 g/m2 on days 1-5)
Trial: 1558794
Drug: High-dose mitoxantrone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose mitoxantrone
Trial: 9096687
Drug: Standard-dose mitoxantrone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-dose mitoxantrone
Trial: 8415897
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg paroxetine per day
Trial: 8078953
Drug: 150 mg
RxNorm normalized name: pectin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg amitriptyline per day
Trial: 3003728
Drug: Enalapril (injection)
RxNorm normalized name: enalapril Injectable Solution
DrugBank: Enalapril (DB00584)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Enalapril (injection)
Trial: 29096426
Drug: RG7342 (0.06-1.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RG7342 (0.06-1.2 mg)
Trial: 2520622
Drug: Cimetropium bromide
RxNorm normalized name: cimetropium bromide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetropium bromide 50 mg t.d.s. for 1 month
Trial: 11829370
Drug: Oral anti-emetics
RxNorm normalized name: Anti Bac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral anti-emetics (maxolon)
Trial: 26782247
Drug: 100% oxygen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100% oxygen via a facemask at a constant flow rate of 3 l/min (O2 group)
Trial: 20478580
Drug: Surveillance with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surveillance with antibiotics only for symptomatic urinary tract infection
Trial: 9288517
Drug: Cold antegrade
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cold antegrade St. Thomas II cardioplegic solution
Trial: 9288517
Drug: Bretschneider cardioplegic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bretschneider cardioplegic solution